We’re living through an extraordinary moment in science, and it’s opening a new era of hope for people affected by disease. Across our BioPharmaceuticals business, we're turning that science into meaningful progress for patients and the healthcare system they rely on.

Progress in oncology is measured by the lives we improve and extend. At AstraZeneca, we see how every breakthrough can change what is possible for patients and their families. That belief is driving us to build the next model of cancer care.

What inspires our work in rare disease is transforming scientific innovation into meaningful impact for patients. At Alexion, AstraZeneca Rare Disease, we build on decades of pioneering innovation to help more patients benefit from timely diagnosis and innovative treatment.